Skip to main content
SpringerLink
Log in

Nichtkleinzelliges Bronchialkarzinom

  • Chapter
Kompendium Internistische Onkologie

Zusammenfassung

Häufigkeit: Häufigste Tumorerkrankung in den westlichen Industrienationen. Von 1940–1980 bei Männern rasch steigende Inzidenz von 10 auf 70 pro 100000, seither Plateau der Erkrankungszahlen in den USA. Beim weiblichen Geschlecht seit 1965 permanent steigende Inzidenz von 5 auf 30 pro 100000. Ca. 90% der Patienten versterben an ihrer Erkrankung. Das Bronchialkarzinom ist daher die häufigste tumorbedingte Todesursache beim Mann und die zweithäufigste (nach dem Mammakarzinom) bei der Frau.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Albain K, Rusch V, Crowley Jet al. (1994) Concurrent cisplatin (DDP), VP16, and chest irradiation (RT) followed by surgery for stages IIIA and IIIB non small cell lung cancer (NSCLC): A Southwest Oncology Group (SWOG) Study (# 8805). Proc Am Soc Clin Oncol 13: 337 (p 1120 )

    Google Scholar 

  • Ayesh R, Idle JR, Ritchie JC et al. (1984) Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312: 169–170

    Article  PubMed  CAS  Google Scholar 

  • Bonomi PD, Finkelstein DM, Ruckdeschl JC et al. (1989) Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: A Study of the Eastern Cooperative Oncology Group. J Clin Oncol 7 (11): 1602–1613

    PubMed  CAS  Google Scholar 

  • Bulzebruck H, Bopp R, Drings P et al. (1992) New aspects in the staging of lung cancer. Cancer 70: 1102–1110

    Article  PubMed  CAS  Google Scholar 

  • Burkes RL, Ginsberg RJ, Shepherd FA et al. (1992) Induction chemotherapy with mitomycin, vindesine, and cisplatin in for stage III unresectable non-small-cell lung cancer: Results of the Toronto phase II trial. J Clin Oncol 10: 580–586

    Google Scholar 

  • Cellerino R, Tummarello D, Piga A (1990) Chemotherapy or not in advanced non-small cell lung cancer. Lung Cancer 6: 99–109

    Article  Google Scholar 

  • Charmack Holes E (1993) Postoperative chemotherapy for non small cell lung cancer. Chest 103: 30–34

    Article  Google Scholar 

  • Choy W, Akerley H, Safran H et al. (1994) Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non small cell lung cancer. J Clin Oncol 12 (12): 2682–2688

    PubMed  CAS  Google Scholar 

  • Crino LM, Clerici F, Figoli F et al. (1995) Chemotherapy of advanced non small cell lung cancer. A comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research ( G.O.I.R.C. ). Ann Oncol 6: 347–353

    Google Scholar 

  • Dilimann RO, Seagren SL, Propert KJ et al. (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non small cell lung cancer. N Engl J Med 323: 940–945

    Article  Google Scholar 

  • Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T, Bombardiere E (1994) CYTOKERTIN 19 fragment CYFRA 21–1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Eur J Clin Chem Clin Biochem 32 (in press)

    Google Scholar 

  • Gatzemeier U, Heckmayr M, Hossfeld DK et al. (1990) Chemotherapie des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms mit Mitomycin-C/ Ifosfamid versus Mitomycin-C/Vindesin versus Cisplatin/Etoposid–Eine randomisierte Studie. Pneumologie 44: 91–674

    Google Scholar 

  • Gatzemeier U, Shepherd F, Le Chevalier T et al. (1995) Activity of gemcitabine in patients with non small lung cancer. A multicentre, extended phase-II-study. Eur J Cancer (in press)

    Google Scholar 

  • Ginsberg RJ (1993) Multimodality therapy for non small cell lung cancer: the role of surgery. Lung Cancer 9 (Suppl 2): 25–30

    Article  Google Scholar 

  • Holmes EG, Gail M (1986) Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferential carcinoma. J Clin Oncol 4: 710–715

    PubMed  CAS  Google Scholar 

  • Johnson DH, Einhorn LH, Bartolussi A et al. (1990) Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non small cell lung cancer. Ann Intern Med 113: 33–38

    Article  PubMed  CAS  Google Scholar 

  • Kik K, Osinga J, Carritt B (1987) Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature 330: 578–581

    Article  Google Scholar 

  • Klatersky J et al. (1989) Cisplatin vs Cisplatin plus Etoposid an the treatment of advanced non small cell lung cancer. J Clin Oncol 7 (8): 1087–1092

    Google Scholar 

  • Konietzko N, Ferlinz R, Loddenkemper R und die Arbeitsgemeinschaft „Diagnostik“ der „Deutschen Gesellschaft für Pneumologie und Tuberkulose” (1983) Präoperative Lungenfunktionsdiagnostik. Prax Klin Pneumol 37: 1199

    Google Scholar 

  • Le Chevalier T, Arriagada R, Quoix E et al. (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non small cell lung carcinoma. J Natl Cancer Inst 83: 417–423

    Article  PubMed  Google Scholar 

  • Levine A, Momand J, Finaly C (1991) The p53 tumor suppressor gene. Nature 351: 453–456

    Article  PubMed  CAS  Google Scholar 

  • Loddenkemper R (1983) Criteria of functional operability in patients with bronchial carcinoma: preoperative assessment of risk and prediction of postoperative function. J Thorac Cardiovasc Surg 31: 334

    Article  CAS  Google Scholar 

  • Manegold C, Fischer JR, Vogt-Moykopf I, Drings P (1994) Induction chemotherapy (ICT) in stage III A/B non-small cell lung cancer (NSCLC). J Cancer Res Clin Onkol 120 [Suppl]: 279

    Article  Google Scholar 

  • Martini N, Kries MG, Flehinger J et al. (1993) Preoperative chemotherapy for stage lIa (N2) lung cancer: The Sloan Kettering experience with 136 patients. Ann Thorac Surg 55: 1365–1374

    Article  PubMed  CAS  Google Scholar 

  • Naruke T, Suemasu K, Ishikawa S (1978) Lymph node mapping and curability of various levels of metastases in resected lung cancer. J Thorax Cardiovasc Surg 76: 832–839

    CAS  Google Scholar 

  • Rosell R, Gomez-Codina J, Camps C et al. (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non small cell lung cancer. N Engl J Med 330: 153–158

    Article  PubMed  CAS  Google Scholar 

  • Rosso R et al. (1988) Etoposie +/- cisplatin in the treatment of advanced non small cell lung cancer (NSCLC): A fonicap randomized trial. Lung Cancer 4 (6):2.27:A 124

    Google Scholar 

  • Roth JA, Fossella F, -Komaki R et al. (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non small cell lung cancer. J Natl Cancer Inst 86 (9):673–680

    Google Scholar 

  • Ruckdeschel JC et al. (1986) A randomized trial of the four most active regimens for metastatic non small cell lung cancer. J Clin Oncol 4 (1): 14–22

    PubMed  CAS  Google Scholar 

  • Rudiger H, Schwartz U, Serrand E et al. (1989) Reduced 06-methylguanine repair in fibroblast cultures from patients with lung cancer. Cancer Res 49: 5623–5626

    PubMed  CAS  Google Scholar 

  • Schaake-Koning C, Van den Bogaert W, Dalesio O et al. (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non small cell lung cancer. N Engl J Med 326: 524–530

    Article  PubMed  CAS  Google Scholar 

  • Schildberg FW, Sunder-Plassmann L (1990) Chirurgische Therapie des Bronchial-carcinomas. Chirurg 61: 558–564

    PubMed  CAS  Google Scholar 

  • Schirren J, Krysa S, Trainer S, Bülzebruck H, Wassenberg D, Di Rienzo N, Branscheid D (1993) Die Technik der systematischen Lymphadenektomie beim Bronchialkarzinom unter besonderer Berücksichtigung am linken Hemithorax. Z Herz-Thorax-Gefäßchir 7: 178–183

    Google Scholar 

  • Seidegard J Pero RW, Müller DG et al. (1986) A gluthathione transferase in human leucocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 751–753

    Google Scholar 

  • Smith ThJ, Hillner BE, Neigbors D et al. (1995) Economic evaluation of a randomized clinical trail comparing vinorelbine, vinorelbine plus cisplatin and vindesine plus cisplatin for non small cell lung cancer. J Clin Oncol 13: 2166–2173

    PubMed  CAS  Google Scholar 

  • Splinter TAW, Verhoeven G, Kho GS, Bos E, Zondervan P (1993) Neoadjuvant chemotherapy in stage 3 non small cell lung cancer (NSCLS): Evaluation of response. Proc ASCO 12: 359 (abs. 1213)

    Google Scholar 

  • Stamatis G, Wilke H, Eberhardt W et al. (1994) Chirurgie des lokal fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms nach intensiver präoperativer Chemo-/Strahlentherapie. Chirurg 65: 42–47

    PubMed  CAS  Google Scholar 

  • Vogt-Moykopf I, Krysa S, Probst G et al. (1991) Die chirurgische Therapie des Bronchialkarzinoms. In: Drings P, Vogt-Moykopf I (Hrsg) Thoraxtumoren. Springer, Berlin Heidelberg New York Tokyo, S 170–186

    Chapter  Google Scholar 

  • Watanabe I, Shimizu J, Oda M (1991) Results of surgical treatment in patients with stage III-A non small cell lung cancer. J Thorac Cardiovasc Surg 39: 44–49

    Article  CAS  Google Scholar 

  • Weick JK, Crowley J, Natale RB et al. (1991) A randomized trial of five cisplatincontaining in patients with metastatic non small cell lung cancer: A Southwest Oncology Group Study. J Clin Oncol 9 (7): 1157–1162

    PubMed  CAS  Google Scholar 

  • Weitberg AB, Yashar J, Glicksman AS et al. (1993) Combined modality therapy for stage IIIA non small cell carcinoma of the lung. Eur J Cancer 29A /4: 511–515

    Article  Google Scholar 

  • Wilke H, Eberhardt W, Stamatis G et al. (1995) High efficacy of an intensive preoperative chemo-radiotherapy for locally far advanced (LAD) NSCLC. Proc Am Soc Clin Oncol 14 /371: 1142

    Google Scholar 

  • Wolf M, Havemann K, Hans K et al. (1989— Spontaneous tumor growth as a selection criterium for chemotherapy in extensive stage non-small cell lung cancer (NSCLC). Proc ECCO 5, Lung Cancer 0–0006

    Google Scholar 

  • Wolf M, Goerg C, Goerg K, Pfab R, Achterrath W, Havemann K (1992) Carboplatin and simultaneous radiation in the treatment of stage IIIA/B non small cell lung cancer. Oncology 49 [Suppl 11: 71–77

    Article  Google Scholar 

  • Wolf M, Merte H, Faoro C et al. (1995) Dose finding study of paclitaxel and simultaneous radiotherapy in stage III non small cell lung cancer NSCLC. Proc Am Soc Clin Oncol 14 /348: 10–52

    Google Scholar 

Download references

Authors
  1. M. Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Havemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Vogt-Moykopf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Budach
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik, Innere Medizin IV, Abteilung Hämatologie/Onkologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, D-06120, Halle/Saale, Deutschland

    Hans-Joachim Schmoll (Direktor) (Direktor)

  2. Klinik und Poliklinik für Innere Medizin II, Klinikum der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, D-07740, Jena, Deutschland

    Klaus Höffken (Direktor) (Direktor)

  3. Medizinischen Klinik II, Schwerpunkt Onkologie und Hämatologie, Humboldt-Universität, Universitätsklinikum Charité, Schumannstraße 20/21, D-10117, Berlin, Deutschland

    Kurt Possinger (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wolf, M., Havemann, K., Schneider, P., Vogt-Moykopf, I., Budach, V. (1997). Nichtkleinzelliges Bronchialkarzinom. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12175-7_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-60830-1

  • Online ISBN: 978-3-662-12175-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation